Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer

Acta Cytologica

Volumn 50, Issue 1, 2006, Pages 6-15

  Branca, Margherita ^a   Giorgi, Colomba ^a   Ciotti, Marco ^b   Santini, Donatella ^c   Di Bonito, Luigi ^d   Costa, Silvano ^c   Benedetto, Arrigo ^b   Bonifacio, Donatella ^d   Di Bonito, Paola ^a   Paba, Pierluigi ^b   Accardi, Luisa ^a   Mariani, Luciano ^e   Syrjänen, Stina ^f   Favalli, Cartesio ^b   Syrjänen, Kari ^a,g  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d MAGGIORE HOSPITAL   (Italy)

^e REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^f UNIVERSITY OF TURKU   (Finland)

^g TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; Human papillomavirus; Laminin receptors; Prognosis

Indexed keywords

DNA; LAMININ RECEPTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; COLPOSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHUMAN; ONCOVIRINAE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS PATHOGENESIS; VIRUS TYPING; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; ONCOVIRINAE;

EID: 31544460170     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325887     Document Type: Article

References (42)

1. Papillomaviruses. Lyon, IARC, 1995, pp 1-409
2. Syrjänen K, Syrjänen S: Papillomavirus Infections in Human Pathology. Chichester, West Sussex, UK, J Wiley & Sons, 2000, pp 1-615
3. zur Hausen H: Papillomaviruses and cancer: From basic studies to clinical application. Nature Rev Cancer 2002;2:342-350
4. Aubin F, Pretet JL Mougin C (editors): Papillomavirus Humains: Biologie et Pathologie Tumorale. Paris, Editions TEC & DOC, 2003, pp 1-759
5. Bosch FX, de Sanjose S: Human papillomavirus and cervical cancer burden and assessment of causality. J Natl Cancer Inst Monogr 2003;31:3-13
6. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527
7. von Knebel Doeberitz M: New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002;38:2229-2242
8. Giarre M, Caldeira S, Malanchi I, Ciccolini F, Leao MJ, Tommasino M: Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle arrest. J Virol 2001;75:4705-4712
9. INK4A Expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol 2004;23:354-365
10. Branca M, Ciotti M, Santini D, Bonito LD, Benedetto A, Giorgi C, Paba P, Favalli C, Costa S, Agarossi A, Alderisio M, Syrjanen K: Activation of the ERK/MAP ldnase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer. Am J Clin Pathol 2004;122:902-911
11. Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Benedetto A, Paba P, Costa S, Bonifacio D, Di Bonito P, Accardi L, Favalli C, Syrjänen K: Aberrant expression of vascular endothelial growth factor-C (VEGF-C) is related to grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J Clin Pathol (in press)
12. Campo E, Monteagudo C, Castronovo V, Claysmith AP, Fernandez PL, Sobel ME: Detection of laminin receptor mRNA in human cancer cell lines and colorectal tissues by in situ hybridisation. Am J Pathol 1992;141:1073-1083
13. Tuszynski GP, Wang TN, Berger D: Adhesive proteins and the hematogenous spread of cancer. Acta Haematol 1997;97:29-39
14. Ménard S, Castronovo V, Tagliabue E, Sobel ME: New insights into the metastases-associated 67kD laminin receptor. J Cell Biochem 1997;67:155-165
15. Castronovo V: Laminin receptors and laminin-binding proteins during tumor invasion and metastasis. Invasion Metastasis 1993;3:1-30
16. Clément B, Segui-Real B, Savagner P, Kleinman HK, Yamada Y: Hepatocyte attachment to laminin is mediated through multiple receptors. J Cell Biol 1990;110:185-192
17. Chattopadhyay N, Ray S, Biswas N, Chatterjee A: Effect of all-trans-retinoic acid on integral receptors of human cervical cancer (SiHa) cells. Gynecol Oncol 1999;75:215-221
18. Rao NC, Barsky SH, Terranova VP, Liotta LA: Isolation of a tumor cell laminin receptor. Biochem Biophys Res Commun 1983;111:804-808.
19. Castronovo V, Taraboletti G, Sobel ME. Functional domains of the 67-kDa laminin receptor precursor. J Bio] Chem 1991;266:20440-20446
20. Hinek A: Nature and the multiple functions of the 67-kD elastin-/lammin binding protein. Cell Adhes Commun 1994;2: 185-193
21. Viacava P, Naccarato AG, Collecchi P, Ménard S, Castronovo V, Bevilacqua G: The spectrum of 67-kD laminin receptor expression in breast carcinoma progression. J Pathol 1997;182: 36-44
22. Lee WA, Kim WH, Kim YI, Yang H-K, Kim J-P, Kleinman HK: Overexpression of the 67kD laminin receptor correlates with the progression of gastric carcinoma. Pathol Res Pract 1996;192:1195-1201
23. Waltregny D, de Leval L, Ménard S, de Leval J, Castronovo V: Independent prognostic value of the 67-kd lalminin receptor in human prostate cancer. J Natl Cancer Inst 1997;89:1224-1227
24. van den Brule FA, Castronovo V, Ménard S, Giavazzi R, Marzola M, Belotti D, Taraboletti G: Expression of the 67kD laminin receptor in human ovarian carcinomas as defined by a monoclonal antibody, MluC5. Eur J Cancer 1996;32A:1598-1602
25. van den Brule FA, Buicu C, Berchuck A, Bast RC, Deprez M, Fu-Tong L, Cooper DNW, Pieters C, Sobel ME, Castronovo V: Expression of the 67-kD laminin receptor, galectin-1 and galectin-3 in advanced human uterine adenocarcinoma. Hum Pathol 1996;27:1185-1191
26. Demeter LM, Stoler MH, Sobel ME, Broker TR, Chow LT: Expression of high-affinity laminin receptor mRNA correlates with cell proliferation rather than invasion in human papillomavirus-associated cervical neoplasms. Cancer Res 1992;52: 1561-1567
27. al-Saleh W, Delvenne P, van den Brule FA, Menard S, Boniver J, Castronovo V: Expression of the 67 KD laminin receptor in human cervical preneoplastic and neoplastic squamous epithelial lesions: An immunohistochemical study. J Pathol 1997;181: 287-293
28. Syrjänen KJ: Immunohistochemistry in assessment of molecular pathogenesis of cervical carcinogenesis. Eur J Gynaecol Oncol 2005;26:118-124
29. Branca M, Costa S, Mariani L, Piccione E, Sesti F, Agarossi A, di Carlo A, Galati M, Ciotti M, Paba P, Benedetto A, Giorgi C, Criscuolo A, Valieri M, Favalli C, Santini D, Alderisio M, De Nuzzo M, di Bonito L, Syrjänen K: Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women: Study design and baseline data of the HPV-PathogenISS study. Eur J Gynaecol Oncol 2004;25:689-698
30. Costa S, Terzano P, Santini D, Panetta A, Martoni A, Bovicelli A, De Nuzzo M, Lipponen P, Erzen M, Syrjänen S, Syrjänen K: CD44 isoform 6 (CD44v6) is a prognostic indicators of the response to neoadjuvant chemotherapy in cervical carcinoma. Gynecol Oncol 2001;80:67-73
31. Costa S, Terzano P, Santini D, Ceccarelli C, Martoni A, Angelelli B, Panetta A, Bovicelli A, Cristiani P, Lipponen P, Erzen M, Syrjänen S, Syrjänen K: Neoadjuvant chemotherapy in cervical carcinoma: Regulators of cell cycle, apoptosis and proliferation as determinants of response to therapy and disease outcome. Am J Clin Pathol 2001;116:729-737
32. Costa S, Simone PD, Venturoli S, Cricca M, Zerbini ML, Musiani M, Terzano P, Santini D, Cristiani P, Syrjänen S, Syrjänen K: Factors predicting human papillomavirus (HPV) clearance in cervical intraepithelial neoplasia (CIN) lesions treated by conization. Gynecol Oncol 2003;90:358-365
33. Martignone S, Pellegrini S, Villa E, Tandon NN, Mastroianni A, Tagliabue E, Ménard S, Colnaghi MI: Characterization of two monoclonal antibodies directed against the 67kDa affinity laminin receptor and application for the study of breast carcinoma progression. Clin Exp Metastasis 1992;10:379-386
34. Bauer HM, Greer CE, Manos M: Determination of genital human papillomavirus infection using consensus PCR. In Diagnostic Molecular Pathology: A Practical Approach. Edited by CS Herrington, JOD McGee. Oxford, Oxford University Press, 1992, pp 132-152
35. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, Johansson B, Hagmar B: Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 1996;34:2095-2100
36. Kleter B, van Doorn LJ, Scrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M, Quint W: Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-2517
37. Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA: Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 1997;71:2449-2456
38. McMillan NA, Payne E, Frazer IH, Evander M: Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology 1999;261:271-279
39. Yamanaka I, Koizumi M, Baba T, Yamashita S, Suzuki T, Kudo R: Epidermal growth factor increased the expression of alpha2beta1-integrin and modulated integrin-mediated signaling in human cervical adenocarcinoma cells. Exp Cell Res 2003;286:165-174
40. Mitra A, Chakrabarti J, Banerji A, Chatterjee A: Binding of alpha2 monoclonal antibody to human cervical tumor cell (SiHa) surface alpha2beta1 integrin modulates MMP-2 activity. Gynecol Oncol 2004;94:33-39
41. Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Costa S, Benedetto A, Casolati EA, Favalli C, Paba P, Di Bonito P, Mariani L, Syrjänen S, Bonifacio D, Accardi L, Zanconati F, Syrjänen K: Aberrant expression of a novel inhibitor of apoptosis (Survivin) is related to grade of cervical intraepithelial neoplasia (CIN), but does not predict virus clearance after cone or prognosis in cervical cancer. Am J Clin Pathol 2005;124:113-121
42. Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Favalli C, Syrjänen K: Down-regulation of nucleoside diphosphate (NDP) kinase nm23-H1 expression is unrelated to high-risk human papillomavirus (HPV) but associated with progression of CIN and unfavourable prognosis of cervical cancer (submitted for publication)